Dare Bioscience Inc (DARE): Next-Year EPS Estimate 49.30%
As of 2026-08-04, Dare Bioscience Inc (DARE) has a next-year EPS growth estimate of 49.30%. Featured in 2 EPS revision reports, most recently on 2026-04-20.
On 2026-05-19, analyst consensus for DARE's next-year EPS growth shifted from 45.45% to 49.30% — a positive change of 3.85 percentage points. The revised estimate has been sustained across 59 subsequent trading sessions. Current-year growth is projected at 21.11%.
What's Driving This
Analysts raised next-year EPS growth estimates from 45.45% to 49.30%, providing a structural catalyst for DARE's rise. The upgrade was supported by the company's initiation of a Phase 2 study for DARE-HPV, a novel treatment for high-risk
Generated 2026-07-29 from news as of 2026-07-29
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 49.30%
- EPS growth this year
- 21.11%
- EPS next quarter (est)
- -$0.30
- Last price
- $1.34
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-04 | 49.30% | 21.11% | -$0.30 | $1.34 |
| 2026-08-03 | 49.30% | 21.11% | -$0.30 | $1.28 |
| 2026-08-02 | 49.30% | 21.11% | -$0.30 | $1.22 |
| 2026-07-31 | 49.30% | 21.11% | -$0.30 | $1.22 |
| 2026-07-30 | 49.30% | 21.11% | -$0.30 | $1.24 |
| 2026-07-29 | 49.30% | 21.11% | -$0.30 | $1.16 |
| 2026-07-28 | 49.30% | 21.11% | -$0.30 | $1.18 |
| 2026-07-27 | 49.30% | 21.11% | -$0.30 | $1.32 |
| 2026-07-26 | 49.30% | 21.11% | -$0.30 | $1.28 |
| 2026-07-24 | 49.30% | 21.11% | -$0.30 | $1.28 |
| 2026-07-23 | 49.30% | 21.11% | -$0.30 | $1.26 |
| 2026-07-22 | 49.30% | 21.11% | -$0.30 | $1.22 |
| 2026-07-21 | 49.30% | 21.11% | -$0.30 | $1.25 |
| 2026-07-20 | 49.30% | 21.11% | -$0.30 | $1.34 |
| 2026-07-19 | 49.30% | 21.11% | -$0.30 | $1.96 |
| 2026-07-17 | 49.30% | 21.11% | -$0.30 | $1.96 |
| 2026-07-16 | 49.30% | 21.11% | -$0.30 | $1.94 |
| 2026-07-15 | 49.30% | 21.11% | -$0.30 | $2.07 |
| 2026-07-14 | 49.30% | 21.11% | -$0.30 | $2.07 |
| 2026-07-13 | 49.30% | 21.11% | -$0.30 | $2.09 |
| 2026-07-12 | 49.30% | 21.11% | -$0.30 | $2.02 |
| 2026-07-09 | 49.30% | 21.11% | -$0.30 | $2.07 |
| 2026-07-08 | 49.30% | 21.11% | -$0.30 | $2.03 |
| 2026-07-07 | 49.30% | 21.11% | -$0.30 | $2.05 |
| 2026-07-06 | 49.30% | 21.11% | -$0.30 | $2.08 |
| 2026-07-05 | 49.30% | 21.11% | -$0.30 | $2.09 |
| 2026-07-02 | 49.30% | 21.11% | -$0.30 | $2.09 |
| 2026-07-01 | 49.30% | 21.11% | -$0.30 | $2.11 |
| 2026-06-30 | 49.30% | 21.11% | -$0.30 | $2.11 |
| 2026-06-29 | 49.30% | 21.11% | -$0.30 | $2.10 |
Reports Featuring DARE
Recent News
- Dare Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved TherapiesGlobeNewswire
- Dare Bioscience Inc (DARE) Q1 2026 Earnings Call Highlights: Strategic Milestones and Financial ...GuruFocus.com
- Dare Bioscience Reports Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Dare Bioscience Inc (DARE) Q4 2025 Earnings Report Preview: What To ExpectGuruFocus.com
Screen Performance
Aggregate stats across all 1911 tickers our top-EPS-revision screen has flagged over the past 125 days.
- Median return since detection
- +4.2%
- % of tickers in the green
- 58%
- Median return on winners
- +20.9%
- Large revisions captured
- 1244
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Dare Bioscience Inc's next-year EPS growth estimate?▾
As of 2026-08-04, Dare Bioscience Inc (DARE) has a next-year EPS growth estimate of 49.30%, based on analyst consensus.
When was the latest EPS estimate revision for DARE?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 45.45% to 49.30%.
What sector and industry does Dare Bioscience Inc belong to?▾
Dare Bioscience Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. DARE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Dare Bioscience Inc (DARE) appears here because it was detected by our daily top-EPS-revision-performer screen.